Why is Pharmaids Pharma falling/rising?

As of 14-Nov, Pharmaids Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at Rs 44.13, which reflects a decrease of Rs 1.68 or 3.67%. The stock has underperformed significantly today, with a performance that is 4.04% lower than its sector. It has also touched an intraday low of Rs 43.9, indicating a drop of 4.17%. The stock is trading below all its moving averages (5-day, 20-day, 50-day, 100-day, and 200-day), and there has been a notable decrease in investor participation, with delivery volume falling by 29.48% compared to the 5-day average. Furthermore, the stock is close to its 52-week low, being only 4.83% away from Rs 42. The year-to-date return is down by 37.39%, and the one-year return shows a decline of 41.90%, highlighting a significant downturn in performance.
In the broader market context, the Sensex has shown a positive return of 1.62% over the past week, contrasting sharply with Pharmaids' decline of 7.46% in the same period. This underperformance is indicative of the stock's struggles relative to the benchmark. Over the past month, while the Sensex has gained 3.09%, Pharmaids has only managed a slight decrease of 1.23%. The stark difference in performance suggests that investor sentiment towards Pharmaids is weak, particularly as it continues to lag behind the broader market trends.